| Lisa M Langhammer, PMHCNS | |
|
940 Belmont St, Brockton, MA 02301 | |
| (774) 826-2079 | |
| Not Available |
| Full Name | Lisa M Langhammer |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health |
| Location | 940 Belmont St, Brockton, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588797625 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa M Langhammer, PMHCNS 940 Belmont St, Brockton, MA 02301-5596 Ph: (774) 826-2079 | Lisa M Langhammer, PMHCNS 940 Belmont St, Brockton, MA 02301 Ph: (774) 826-2079 |
News Archive
Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).
Shire plc , the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of Shire's 4 mg guanfacine hydrochloride extended release tablet, INTUNIV.
By employing a third reactant, researchers at Boston College have developed a new type of 'cross coupling' chemical reaction, building on a Nobel Prize-winning technique that is one of the most sophisticated tools available to research chemists, the team reports in the journal Science.
Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients, complex intermediates and contract manufacturing services to customers located in 85 countries, today announced financial results for the first quarter of fiscal year 2014, ended June 30, 2013.
Bayer HealthCare today announced data from the Phase III CHEST-1 trial evaluating its investigational drug riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or with persistent or recurrent pulmonary hypertension (PH) after surgery.
› Verified 3 days ago
Dr. Karen Hetzel, PHD, APRN, BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1342 Belmont St, Suite 101, Brockton, MA 02301 Phone: 508-583-1600 | |
Maureen Dumas-lipka, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 110 Liberty St, Brockton, MA 00301 Phone: 508-894-0400 Fax: 508-894-0342 | |
Monique Mitchell, PMHCNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 22 Christy Dr, Brockton, MA 02301 Phone: 508-580-4611 | |
Mrs. Norah P Connolly, FNP-C Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 680 Centre Street, Signature Healthcare Brockton Hospital, Brockton, MA 02302 Phone: 508-941-7355 Fax: 508-941-6206 | |
Ms. Denise Lucille Jezewski, RN ACNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 45 Pearl St, Brockton, MA 02301 Phone: 508-586-4688 Fax: 508-584-3279 | |
Joan Stack Kovach, APRN, BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: Mclean Hospital Southeast Location, 940 Belmont Street, Brockton, MA 02301 Phone: 508-894-8316 Fax: 508-894-8334 | |
Linda M Meehan, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 529 Pearl Street, Brockton, MA 02301 Phone: 508-580-2211 |